Is There a Future for AKT Inhibitors in the Treatment of Cancer?

被引：36
|
作者：
Jansen, Valerie M. [1 ]
Mayer, Ingrid A. [1 ]
Arteaga, Carlos L. [1 ]
机构：
[1] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Breast Canc Program, Nashville, TN 37232 USA
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷 / 11期
关键词：
METASTATIC BREAST-CANCER; COMBINATION; THERAPY; DOMAIN;
D O I：
10.1158/1078-0432.CCR-16-0100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
An AKT inhibitor plus an antiestrogen exhibited no significant clinical activity in patients with ER+/HER2(-) breast cancer despite laboratory studies supporting an antitumor effect for both drugs combined. These results raise concerns about the development of AKT inhibitors in unselected patients whose tumors have unknown dependence on the PI3K/AKT pathway. (C) 2016 AACR.
引用
收藏
页码：2599 / 2601
页数：3
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
    Thomas, Remy
    Al-Khadairi, Ghaneya
    Decock, Julie
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [32] Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
    Jhaveri, Komal
    Ochiana, Stefan O.
    Dunphy, Mark P. S.
    Gerecitano, John F.
    Corben, Adriana D.
    Peter, Radu I.
    Janjigian, Yelena Y.
    Gomes-DaGama, Erica M.
    Koren, John, III
    Modi, Shanu
    Chiosis, Gabriela
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 611 - 628
  • [33] TREATMENT OF BREAST-CANCER WITH AROMATASE INHIBITORS - CURRENT STATUS AND FUTURE-PROSPECTS
    LONNING, PE
    DOWSETT, M
    POWLES, TJ
    BRITISH JOURNAL OF CANCER, 1989, 60 (01) : 5 - 8
  • [34] 'The future of cancer treatment'
    O'Keefe, B
    FORTUNE, 2001, 144 (02) : 80 - 80
  • [35] Akt inhibitors induce Akt activation
    Okuzumi, Tatsuya
    Fiedler, Dorothea
    Zhang, Chao
    Gray, Daniel C.
    Aizenstein, Brian
    Hoffman, Randy
    Shokat, Kevan M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [36] AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
    Martorana, Federica
    Motta, Gianmarco
    Pavone, Giuliana
    Motta, Lucia
    Stella, Stefania
    Vitale, Silvia Rita
    Manzella, Livia
    Vigneri, Paolo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] The Future of Combination Treatment With Checkpoint Inhibitors in Melanoma
    Sullivan, Ryan J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 96 - 99
  • [38] Entry inhibitors and future treatment of hepatitis C
    Fofana, Isabel
    Jilg, Nikolaus
    Chung, Raymond T.
    Baumert, Thomas F.
    ANTIVIRAL RESEARCH, 2014, 104 : 136 - 142
  • [39] Future treatment of Diabetes - Tyrosine Kinase inhibitors
    Kumar, S. Aakash
    Patel, Snehal S.
    Patel, Shreya
    Parikh, Palak
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 61 - 71
  • [40] Future treatment of Diabetes – Tyrosine Kinase inhibitors
    Aakash Kumar S
    Snehal S Patel
    Shreya Patel
    Palak Parikh
    Journal of Diabetes & Metabolic Disorders, 2023, 22 : 61 - 71
12345